Correlation between HbA1c level and monocyte percentage in obesity

*Edward Kurnia Setiawan Limijadi  -  Department of Clinical Pathology, Faculty of Medical, Universitas Diponegoro, Indonesia
Meita Hendrianingtyas  -  Department of Clinical Pathology, Faculty of Medical, Universitas Diponegoro, Indonesia
Received: 15 Nov 2019; Published: 6 Feb 2020.
Open Access
Citation Format:
Article Info
Section: Articles
Language: EN
Statistics: 190 104
Abstract

Background : HbA1c is one of the parameters that can be useful for diagnosing diabetes mellitus that can occur in obesity. Monocyte as an inflammatory cell is widely studied in relation to diabetes mellitus and obesity. The purpose of this study is to analyze the correlation between HbA1c levels and monocyte percentage in obesity.

Methods : A Cross-sectional study of 30 medical students at a private laboratory in Semarang on March – April 2017 was done. The monocyte percentage included incomplete blood count was examined with the Sysmex XS-800i hematology analyzer, while HbA1c level was examined with Hemocue HbA1c 501 System. Spearman test was done for analyzing data with p <0.05 was considered statistically significant.

Result and discussion : Median of HbA1c level was 5.8 ± 0.23%. Medians of leukocyte count, lymphocyte percentage, neutrophil percentage, and monocyte percentage were 8,600 ± 339,77 /μl, lymphocyte percentage 33% ± 1.19%, neutrophil percentage 56% ± 1.35%, and monocyte percentage of 9.0% ± 0.26%, respectively. Spearman test showed that correlation value (r) was 0.131 (p = 0.489).

Conclusion and suggestion : There was no correlation between HbA1c levels and monocyte percentage in obesity. The increased of monocyte percentage can be used as monitoring and evaluation parameters in obesity that can lead to diabetes mellitus. Further study can be done in an obese population with older age as well as other parameters related to obesity and diabetes mellitus.

Keywords: HbA1c level; monocyte percentage; obesity

Article Metrics:

  1. World Health Organization. Obesity and overweight. WHO technical report series. Geneva.WHO; 2013.
  2. Soegih R, Kunkun. Obesitas (permasalahan dan terapi praktis). Jakarta. Sagung Seto; 2009.
  3. Hruby A., Hu FB. The Epidemiology of obesity: A Big Picture. Pharmacoeconomics. 2015. 33(7): 673–89.
  4. Sundari E., Masdar H., Rosdiana D. Angka Kejadian obesitas sentral
  5. pada masyarakat kota Pekanbaru. JOM FK. 2015. 2(2);1-16.
  6. Badan Penelitian dan Pengembangan Kesehatan Departemen Kesehatan Republik Indonesia. Riset kesehatan dasar nasional 2018.
  7. Jian PY. Mechanism of insulin resistance in obesity. Front Med. 2013. 7(1):14-24
  8. Robert VC. Activated monocytes: yet another link between
  9. systemic inflammation and obesity. J Clin Endocrinol Metab. 2014. 99(7):2347–9.
  10. Gael B., Robert C., Bruno D, Corinne C, Violeta R., Marie P., et al. Impaired alternative macrophage differentiation of peripheral blood
  11. mononuclear cells from obese subjects. Diab Vasc Dis Res. 2015. 30:1-7.
  12. Amano, SU, Cohen JL, Vangala P., Tencerova M., Nicoloro SM, et al. Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation. Cell Metabolism. 2014. 19:162–71.
  13. Onal ZE, Atasayan V., Gurbiz T, Hepkaya E, Nuhoglu C. Association of glycosylated hemoglobin (HbA1c) levels with Iinsulin resistance in obese children. Afr Health Sci. 2014. 14(3): 533–8.
  14. Lee HS, Park HK, Hwang JS. HbA1c and glucose intolerance in obese children and adolescents. Diabet Med. 2012. 29(7):e102-5.
  15. Emeribe AU, Elochukwu AC, Nasir1 IA, Bassey IE, Udoh EA. Clinical significance of glycated hemoglobin testing in obese subjects attending a tertiary hospital at Calabar, Nigeria. Sub-Saharan African Journal of Medicine. 2015. 2(3):134-41.
  16. Breslin WL, Johnston CA, Strohacker K., Carpenter KC, Davidson TR, Moreno JP. Obese mexican american children have elevated MCP-1, TNF-a, monocyte concentration, and dyslipidemia. Pediatrics. 2015. 129(5):e1180-6.
  17. Devêvre EF, Renovato-Martins M, Clément K, Sautès-Fridman C, Cremer I, Poitou C.Profiling of the three circulating monocyte subpopulations in human obesity. J Immunol. 2015. 194(8):3917-23.
  18. Mattos RT, Medeiros NI, Menezes CA, Fares RCG, Franco EP, Dutra WO. Chronic low-grade inflammation in childhood obesity is associated with decreased IL-10 expression by monocyte subsets. PLoS ONE. 2016. 11(12): e0168610.
  19. Liu S., Hempe JM, McCarter RJ, Li S, Foseca VA. Association between Inflammation and biological variation in Hemoglobin A1c in U.S. nondiabetic adults. J Clin Endocrinol Metab. 2015;100(6):2364-71.
  20. Kohut M., Hallam J., Hodgkins S, Hurt T., Russell D., Lannginham-Foster L., et al. Association between immune response and the physiological and psychosocial factors that may predict development of type 2 diabetes in African American women. Brain, Behavior and Immunity. 2014;40:e52.
  21. Medzhitov, R. Origin and physiological roles of inflammation. Nature. 2008:454(7203):428–35.
  22. Un JJ., Myung SC., Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014. 15(4): 6184–223.
  23. Anna R., Jordi C., Carlos AV, Jorge J. Insulin resistance, inflammation, and obesity: role of monocyte chemoattractant protein-1 (or CCL2) in the Regulation of metabolism. Hindawi Publishing Corporation. 2010:1-11.
  24. Henson, PM. dan Hume, HA. Apoptotic cell removal in
  25. development and tissue homeostasis. Trends in Immunology. 2006. 27(5):244–50.
  26. Thomas AW, Kevin MV. Macrophages in tissue repair, regeneration, and fibrosis. Immunity. 2016. 44(3): 450–62.
  27. Stephens M, Ludgate M, Rees DA. Brown fat and obesity: the
  28. next big thing? Clin Endocrinol (Oxf). 2011. 74:661-70.
  29. Juonala M, Magnussen CG, Berenson GS, et al. Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med. 2011. 365:1876-85.
  30. Shimizu I., Yoshida Y., Minamino T. Pathological role of adipose tissue dysfunction in cardio-metabolic disorders. Int Heart J. 2015. 56(3):255-9.